Idir Ghout

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

Louis Bernard, Aurélien Dinh, Idir Ghout et al. · The Lancet · 2014 · 464 citations

Antibiotics, Antimicrobial Stewardship, Pyogenic Vertebral Osteomyelitis +6

In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study

Marianne Leruez‐Ville, Idir Ghout, L. Bussières et al. · American Journal of Obstetrics and Gynecology · 2016 · 227 citations · Full text

Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy

Valentine Faure‐Bardon, Jean-François Magny, Marine Parodi et al. · Clinical Infectious Diseases · 2018 · 217 citations

Neonatology, Immunodeficiencies, Immunology +24

Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection

Marianne Leruez‐Ville, Jean‐François Magny, Sophie Couderc et al. · Clinical Infectious Diseases · 2017 · 199 citations

Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study

P. Denys, L. Le Normand, Idir Ghout et al. · European Urology · 2011 · 162 citations

Urological Research, Urology, Voiding Dysfunction +4